124 related articles for article (PubMed ID: 32212330)
1. Prevalence of ABCC3-1767G/A polymorphism among patients with antiretroviral-associated hepatotoxicity.
Singh H; Lata S; Choudhari R; Dhole TN
Mol Genet Genomic Med; 2020 Jun; 8(6):e1124. PubMed ID: 32212330
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of CYP2B6 516G>T polymorphism in patients with ARV-associated hepatotoxicity.
Singh H; Lata S; Dhole TN; Gangakhedkar RR
Mol Genet Genomic Med; 2019 Apr; 7(4):e00598. PubMed ID: 30864294
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of Interleukin-2 (330 G/T) Promoter Polymorphism in ARV associated hepatotoxicity.
Singh H; Nambiar N; Samani D; Gangakhedkar RR
Curr Mol Med; 2019; 19(3):206-215. PubMed ID: 30973108
[TBL] [Abstract][Full Text] [Related]
4. CYP1A1m1 and CYP2C9*2 and *3 polymorphism and risk to develop ARV-associated hepatotoxicity and its severity.
Singh H; Lata S; Nema V; Samani D; Ghate M; Gangakhedkar RR
APMIS; 2017 Jun; 125(6):523-535. PubMed ID: 28370504
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of CYP2D6*4 1934G/A polymorphism in Western Indian HIV patients.
Singh H; Lata S; Gangakhedkar RR
APMIS; 2018 Nov; 126(11):842-851. PubMed ID: 30357957
[TBL] [Abstract][Full Text] [Related]
6. Impact of GSTM1, GSTT1 and GSTP1 gene polymorphism and risk of ARV-associated hepatotoxicity in HIV-infected individuals and its modulation.
Singh HO; Lata S; Angadi M; Bapat S; Pawar J; Nema V; Ghate MV; Sahay S; Gangakhedkar RR
Pharmacogenomics J; 2017 Jan; 17(1):53-60. PubMed ID: 26667829
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-10 polymorphisms and susceptibility to ARV associated hepatotoxicity.
Singh H; Samani D; Nain S; Dhole TN
Microb Pathog; 2019 Aug; 133():103544. PubMed ID: 31121270
[TBL] [Abstract][Full Text] [Related]
8. KDR polymorphism (1192G/A, 1719A/T) and modulation of ARV drug-induced hepatotoxicity.
Singh H; Samani D; Jadhav S
Microb Pathog; 2021 Dec; 161(Pt A):105243. PubMed ID: 34656700
[TBL] [Abstract][Full Text] [Related]
9. Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy.
Giacomelli A; Riva A; Falvella FS; Oreni ML; Cattaneo D; Cheli S; Renisi G; Di Cristo V; Lupo A; Clementi E; Rusconi S; Galli M; Ridolfo AL
BMC Infect Dis; 2018 Nov; 18(1):556. PubMed ID: 30419834
[TBL] [Abstract][Full Text] [Related]
10. IL-1RN and IL-1
Singh H; Samani D; Nema V; Ghate MV; Gangakhedkar RR
Mediators Inflamm; 2018; 2018():4398150. PubMed ID: 29849489
[TBL] [Abstract][Full Text] [Related]
11. Nevirapine-induced hepatotoxicity and pharmacogenetics: a retrospective study in a population from Mozambique.
Ciccacci C; Borgiani P; Ceffa S; Sirianni E; Marazzi MC; Altan AM; Paturzo G; Bramanti P; Novelli G; Palombi L
Pharmacogenomics; 2010 Jan; 11(1):23-31. PubMed ID: 20017669
[TBL] [Abstract][Full Text] [Related]
12. Systematic screening of human ABCC3 polymorphisms and their effects on MRP3 expression and function.
Sasaki T; Hirota T; Ryokai Y; Kobayashi D; Kimura M; Irie S; Higuchi S; Ieiri I
Drug Metab Pharmacokinet; 2011; 26(4):374-86. PubMed ID: 21512263
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis.
Ben Mahmoud L; Ghozzi H; Kamoun A; Hakim A; Hachicha H; Hammami S; Sahnoun Z; Zalila N; Makni H; Zeghal K
Pathol Biol (Paris); 2012 Oct; 60(5):324-30. PubMed ID: 21856096
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in miRNAs Gene (146a, 149, 196a) and Susceptibility to ARV-associated Hepatotoxicity.
Singh HO; Jadhav S; Samani D; Dhole TN
Curr Genomics; 2019 Feb; 20(2):134-150. PubMed ID: 31555064
[TBL] [Abstract][Full Text] [Related]
15. Efffect of the ABCC3 -211C/T polymorphism on clopidogrel responsiveness in patients with percutaneous coronary intervention.
Zou JJ; Fan HW; Chen SL; Tan J; He BS; Xie HG
Clin Exp Pharmacol Physiol; 2013 Aug; 40(8):504-9. PubMed ID: 23692149
[TBL] [Abstract][Full Text] [Related]
16. Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs.
Petros Z; Lee MT; Takahashi A; Zhang Y; Yimer G; Habtewold A; Schuppe-Koistinen I; Mushiroda T; Makonnen E; Kubo M; Aklillu E
OMICS; 2017 Apr; 21(4):207-216. PubMed ID: 28388302
[TBL] [Abstract][Full Text] [Related]
17. N-acetyltransferase and cytochrome P450 2E1 gene polymorphisms and susceptibility to antituberculosis drug hepatotoxicity in an Indian population.
Mishra S; Daschakraborty S; Shukla P; Kapoor P; Aggarwal R
Natl Med J India; 2013; 26(5):260-5. PubMed ID: 25017831
[TBL] [Abstract][Full Text] [Related]
18. Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes.
Daly AK; Aithal GP; Leathart JB; Swainsbury RA; Dang TS; Day CP
Gastroenterology; 2007 Jan; 132(1):272-81. PubMed ID: 17241877
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis of nonsynonymous single nucleotide polymorphism type ATP-binding cassette transmembrane transporter subfamily C member 3.
Kobayashi K; Ito K; Takada T; Sugiyama Y; Suzuki H
Pharmacogenet Genomics; 2008 Sep; 18(9):823-33. PubMed ID: 18698235
[TBL] [Abstract][Full Text] [Related]
20. Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India.
Gupta VH; Amarapurkar DN; Singh M; Sasi P; Joshi JM; Baijal R; Ramegowda PH; Amarapurkar AD; Joshi K; Wangikar PP
J Gastroenterol Hepatol; 2013 Aug; 28(8):1368-74. PubMed ID: 23875638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
